10,198 reports of this reaction
3.5% of all MORPHINE SULFATE reports
#8 most reported adverse reaction
DRUG HYPERSENSITIVITY is the #8 most commonly reported adverse reaction for MORPHINE SULFATE, manufactured by Rhodes Pharmaceuticals L.P.. There are 10,198 FDA adverse event reports linking MORPHINE SULFATE to DRUG HYPERSENSITIVITY. This represents approximately 3.5% of all 294,935 adverse event reports for this drug.
MORPHINE SULFATE has an overall safety score of 92 out of 100. Patients taking MORPHINE SULFATE who experience drug hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG HYPERSENSITIVITY is moderately reported among MORPHINE SULFATE users, representing a notable but not dominant share of adverse events.
In addition to drug hypersensitivity, the following adverse reactions have been reported for MORPHINE SULFATE:
The following drugs have also been linked to drug hypersensitivity in FDA adverse event reports:
DRUG HYPERSENSITIVITY has been reported as an adverse event in 10,198 FDA reports for MORPHINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG HYPERSENSITIVITY accounts for approximately 3.5% of all adverse event reports for MORPHINE SULFATE, making it a notable side effect.
If you experience drug hypersensitivity while taking MORPHINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.